Skip directly to content

ALK in NSCLC

Globally, lung cancer is one of the most commonly reported cancers, with approximately 1.6 million new cases worldwide each year. 1 Approximately 80% of lung cancers are non-small cell lung cancer (NSCLC). 1 The prognosis for patients with lung cancer is poor.

Read more

Testing for ALK

Having established the importance of testing for anaplastic lymphoma kinase (ALK) gene rearrangements in non-small cell lung cancer (NSCLC), this section will provide evidence-based guidance on who should be tested, when they should be tested, and how to perform the tests.

Read more

Expert Opinion

Home